Results of a randomized double-blind crossover trial of scopolamine versus placebo administered by transdermal patch for the control of cisplatin-induced emesis

Cancer Treat Rep. 1982 Nov;66(11):1975-6.

Abstract

We tested the efficacy of scopolamine delivered by transdermal patch in preventing emesis induced by cisplatin as a single agent or in combination. The administration of scopolamine by transdermal patch resulted in acceptable side effects but was ineffective in controlling cisplatin-induced emesis.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Cisplatin / adverse effects*
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasms / drug therapy
  • Placebos
  • Scopolamine / administration & dosage
  • Scopolamine / therapeutic use*
  • Vomiting / chemically induced
  • Vomiting / prevention & control*

Substances

  • Placebos
  • Scopolamine
  • Cisplatin